no image available Dickens & Co. "A Beacon of Hope: Inotuzumab Ozogamicin's Promising Journey Against Childhood Cancer" "A Novel Immunotherapy for High-Risk Acute Lymphoblastic Leukemia: Harnessing the Power of CD22" Price: 22.00€